I'm wondering how much collaboration with Clear Creek Bio or plans to form a company with Roivant Sciences to sell a medicine for ulcerative colitis - will "mitigate" the serious decline in sales of Covid products. When I bought the shares initially, I knew that I could not count on PFE as a long-term investment.
There are no replies in this thread yet. Be the first to post a reply below: